NCPA supports two pieces of legislation reintroduced in the Senate Thursday that will bring transparency to PBMs. Sens. Maria Cantwell (D-Wash.) and Chuck Grassley (R-Iowa) are reintroducing the PBM Transparency Act (S. 127), and the Prescription Pricing for the People Act (S. 113). “We’re grateful to Sens. Cantwell and Grassley for continuing fighting to pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices,” said Anne Cassity, NCPA’s senior vice president of government affairs, in response to the reintroduction of the bills. “Policymakers, including those at the FTC, must act with urgency and ignore the mega-PBMs' predictable attempts to slow down progress. For the sake of patients and independent pharmacies, reforms can’t come soon enough.” Read more about the bills here.